Prostate Cancer News – PRX302 (topsalysin) may help men avoid radical treatment

Prostate Cancer News – PRX302 (topsalysin) may help men avoid radical treatment

This new trial is very exciting” for localised prostate cancer. PRX302 (topsalysin).

Read what Prof Mark Emberton has to say about this new trial.

The research leader Dr Hashim Ahmed says that this treatment could help some men avaoid radicl surgery or radiation therapy.

See More

Read more on Sophiris Bio’s release of promising biopsy data from the first 7 prostate cancer patients treated with topsalysin in a Phase 2a clinical trial.
prostatecancernewstoday.com
No Comments

Post A Comment